» Articles » PMID: 31959744

P53 and Parkin Co-regulate Mitophagy in Bone Marrow Mesenchymal Stem Cells to Promote the Repair of Early Steroid-induced Osteonecrosis of the Femoral Head

Overview
Journal Cell Death Dis
Date 2020 Jan 22
PMID 31959744
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Survival and stemness of bone marrow mesenchymal stem cells (BMSCs) in osteonecrotic areas are especially important in the treatment of early steroid-induced osteonecrosis of the femoral head (ONFH). We had previously used BMSCs to repair early steroid-induced ONFH, but the transplanted BMSCs underwent a great deal of stress-induced apoptosis and aging in the oxidative-stress (OS) microenvironment of the femoral-head necrotic area, which limited their efficacy. Our subsequent studies have shown that under OS, massive accumulation of damaged mitochondria in cells is an important factor leading to stress-induced apoptosis and senescence of BMSCs. The main reason for this accumulation is that OS leads to upregulation of protein 53 (P53), which inhibits mitochondrial translocation of Parkin and activation of Parkin's E3 ubiquitin ligase, which decreases the level of mitophagy and leads to failure of cells to effectively remove damaged mitochondria. However, P53 downregulation can effectively reverse this process. Therefore, we upregulated Parkin and downregulated P53 in BMSCs. We found that this significantly enhanced mitophagy in BMSCs, decreased the accumulation of damaged mitochondria in cells, effectively resisted stress-induced BMSCs apoptosis and senescence, and improved the effect of BMSCs transplantation on early steroid-induced ONFH.

Citing Articles

Potential efficacy and mechanisms of icariin for the animal model of osteonecrosis of the femoral head.

Xu J, Deng W, Zhu X, Han D, Zheng Y, Zheng Q Front Pharmacol. 2025; 16:1508971.

PMID: 40046737 PMC: 11880249. DOI: 10.3389/fphar.2025.1508971.


Rejuvenation of Bone Marrow Mesenchymal Stem Cells: Mechanisms and Their Application in Senile Osteoporosis Treatment.

Tian R, Zhang R, Ma C Biomolecules. 2025; 15(2).

PMID: 40001580 PMC: 11853522. DOI: 10.3390/biom15020276.


Exosomal non-coding RNAs in the regulation of bone metabolism homeostasis: Molecular mechanism and therapeutic potential.

Huang C, Xiao Y, Qing L, Tang J, Wu P Heliyon. 2025; 11(2):e41632.

PMID: 39911437 PMC: 11795052. DOI: 10.1016/j.heliyon.2025.e41632.


Suppressing the Aging Phenotype of Mesenchymal Stromal Cells: Are We Ready for Clinical Translation?.

Roato I, Visca M, Mussano F Biomedicines. 2025; 12(12.

PMID: 39767719 PMC: 11673080. DOI: 10.3390/biomedicines12122811.


Curcumin liposomes alleviate senescence of bone marrow mesenchymal stem cells by activating mitophagy.

Li W, Huang Y, Fan L, Yangzom D, Zhang K, Shen L Sci Rep. 2024; 14(1):31291.

PMID: 39732809 PMC: 11682429. DOI: 10.1038/s41598-024-82614-1.


References
1.
Peng W, Wang L . Adenovirus-Mediated Expression of BMP-2 and BFGF in Bone Marrow Mesenchymal Stem Cells Combined with Demineralized Bone Matrix For Repair of Femoral Head Osteonecrosis in Beagle Dogs. Cell Physiol Biochem. 2017; 43(4):1648-1662. DOI: 10.1159/000484026. View

2.
Liao H, Zhong Z, Liu Z, Li L, Ling Z, Zou X . Bone mesenchymal stem cells co-expressing VEGF and BMP-6 genes to combat avascular necrosis of the femoral head. Exp Ther Med. 2018; 15(1):954-962. PMC: 5772743. DOI: 10.3892/etm.2017.5455. View

3.
Zhang F, Peng W, Wang L, Zhang J, Dong W, Wu J . Role of FGF-2 Transfected Bone Marrow Mesenchymal Stem Cells in Engineered Bone Tissue for Repair of Avascular Necrosis of Femoral Head in Rabbits. Cell Physiol Biochem. 2018; 48(2):773-784. DOI: 10.1159/000491906. View

4.
Fan L, Zhang C, Yu Z, Shi Z, Dang X, Wang K . Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and osteogenesis in rabbit femoral head osteonecrosis. Bone. 2015; 81:544-553. DOI: 10.1016/j.bone.2015.09.005. View

5.
Hu X, Wang L, Xiang G, Lei W, Feng Y . Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes. Acta Biomater. 2018; 73:470-487. DOI: 10.1016/j.actbio.2018.04.008. View